A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer

Breast

Volumn 16, Issue 5, 2007, Pages 520-526

  Konstantiniuk, Peter ^a   Schrenk, Peter ^b   Reitsamer, Roland ^c   Koeberle Wuehrer, Roswitha ^d   Tausch, Christoph ^b   Roka, Sebastian ^c   Riedl, Otto ^c   Poestlberger, Sabine ^e   Hecke, Dieter ^e   Janauer, Michael ^f   Haid, Anton ^d  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d Hospital Feldkirch   (Austria)

^e Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^f GENERAL HOSPITAL LINZ   (Austria)

Author keywords

Breast cancer; Disease free survival; Follow up; Overall survival; Recurrences; Sentinel node biopsy

Indexed keywords

ADULT; ARTICLE; AUSTRIA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE RISK; SAFETY; SENTINEL LYMPH NODE BIOPSY;

EID: 34848892732     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.04.001     Document Type: Article

References (25)

1. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 6 (2003) 603-605
2. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 225 1 (1997) 126-127
3. Krag D., Weaver D., Ashikaga T., Moffat F., Klimberg V.S., Shriver C., et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 339 14 (1998) 941-946
4. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
5. Baron R.H., Fey J.V., Borgen P.I., and Van Zee K.J. Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 13 4 (2004) 691-698
6. Peintinger F., Reitsamer R., Stranzl H., and Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89 4 (2003) 648-652
7. Blanchard D.K., Donohue J., Reynolds C., et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138 (2003) 482-488
8. Mansel R.E., Fallowfield L., Kissin M., Goyal A., Newcombe R.G., Dixon J.M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 9 (2006) 599-609
9. Haid A., Kuehn T., Konstantiniuk P., Koeberle-Wuehrer R., Knauer M., and Kreienberg R. Zimmermann G: shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28 7 (2002) 705-710
10. Zavagno G., Carcoforo P., Franchini Z., Renier M., Barutta L., De Salvo G.L., et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol 31 7 (2005) 715-720
11. Jeruss J.S., Winchester D.J., Sener S.F., Brinkmann E.M., Bilimoria M.M., Barrera E., et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12 (2005) 34-40
12. Janssen S.M.M., Smidt M.L., Bruggink E.D., and Strobbe L.J. Axillary recurrences after negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 11 (2004) 276
13. Roka S., Konstantiniuk P., Heck D., Schrenk P., Jagoutz-Herzlinger M., Koeberle-Wuehrer R., et al. Axillary recurrence after sentinel node biopsy. Eur Surg 34 (2002) 280-282
14. Fan Y.G., Tan Y.Y., Treseler P., Lu Y., Chan C.W., Hwang S., et al. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol 12 9 (2005) 705-711
15. Langer I., Marti W.R., Guller U., Moch H., Harder F., Oertli D., et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241 1 (2005) 152-158
16. Naik A.M., Fey J., Gemignani M., Heerdt A., Montgomery L., Petrek J., et al. The risk of axillary relapse after sentinel loymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 3 (2004) 462-468
17. Konstantiniuk P, Kowatsch E, Haid A, Bauer C, Steindorfer P. Das Multi Center Database Project (MCDBP) Acta Chir Austriaca 2001;33:201.
18. 99mTC-labelled colloid, based on a multicenter database project in Austria. Eur Surg 34 (2002) 272-276
19. Rudas M., Konstantiniuk P., Horvat R., Niedermoser P., Bogner S., Pichler-Gebhard B., et al. Sentinel node examination: balancing between high workload and low metastases detection rate. Eur Surg 34 (2002) 277-279
20. Peters-Engl C., Konstantiniuk P., Tausch C., Haid A., Hoffmann B., Jagoutz-Herzlinger M., et al. Austrian Sentinel Node Biopsy Study Group: the impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian Sentinel Node Biopsy Study Group. Br J Cancer 91 10 (2004) 1782-1786
21. Jakesz R., Hausmaninger H., Kubista E., Gnant M., Menzel C., Bauernhofer T., et al. Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and flourouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients in hormon-responsive breast cancer-Austrian Breast and Colorectal Study Group Trial 5. J Clin Oncol 20 (2002) 4621-4627
22. Wright F.C., Walker J., Law L., et al. Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol 10 (2003) 1054-1058
23. Clemons M., Danson S., Hamilton T., and Gross P. Locoregionally recurrent breast cancer: incidence, risk factors, and survival. Cancer Treat Rev 27 (2001) 67-82
24. Goyal A, Newcombe RG, Chhabra A, Mansel RE on behalf of the ALMANAC Trialists Group. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat 2006;99(2):203-208.
25. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., and Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347 (2002) 567-575